Valerie Haertel | Senior Vice President, Investor Relations |
Larry Merlo | President and Chief Executive Officer |
Eva Boratto | Executive Vice President and Chief Financial Officer |
Jon Roberts | Executive Vice President and Chief Operating Officer |
Alan Lotvin | Executive Vice President, CVS Health and President, CVS Caremark |
Karen Lynch | Executive Vice President, CVS Health and President, Aetna Business Unit |
George Hill | Deutsche Bank |
Michael Cherny | Bank of America Merrill Lynch |
Ricky Goldwasser | Morgan Stanley |
Eric Percher | Nephron Research |
Justin Lake | Wolfe Research |
Robert Jones | Goldman Sachs |
Steven Valiquette | Barclays |
Stephen Tanal | SVB Leerink |
Lance Wilkes | Bernstein |
Ladies and gentlemen, good morning, and welcome to the CVS Health Second Quarter 2020 Earnings Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow CVS Health's prepared remarks at which point we will review instructions on how to ask your questions.
As a reminder, today's conference is being recorded. I would now like to turn the call over to Valerie Haertel, Senior Vice President of Investor Relations for CVS Health.